"We remain optimistic that the current pause in the COUNTER HF study will be resolved expeditiously. In fact, the CEC (Clinical Events Committee) has adjudicated all four events as non-device and non-procedure related deaths and we look forward to receiving a positive response from the FDA no later than April 16th," commented Dave Rosa, President and Chief Executive Officer of Sunshine Heart."
- Forums
- ASX - By Stock
- SHC
- 2014 full year results & corporate update
2014 full year results & corporate update, page-2
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)